carbapenems has been researched along with Febrile Neutropenia in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (73.33) | 24.3611 |
| 2020's | 4 (26.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abbara, S; Alviset, S; Batista, R; Bouscary, D; Canouï, E; Casetta, A; Charlier, C; Charpentier, J; Chentouh, R; Contejean, A; Gastli, N; Grignano, E; Kernéis, S; Pène, F; Reboul-Marty, J; Willems, L | 1 |
| Wu, SQ; Zhan, R | 1 |
| Chen, L; Jiang, J; Li, X; Li, Y; Liang, X; Tang, X | 1 |
| Bernardi, M; Castagna, A; Castiglion, B; Ciceri, F; Clerici, D; Corti, C; Farina, F; Giglio, F; Greco, R; Liberatore, C; Lorentino, F; Mastaglio, S; Oltolini, C; Pavesi, F; Peccatori, J; Ripa, M; Scarpellini, P; Tassan Din, C | 1 |
| Alp, E; Çetin, M; Elmali, F; Kaynar, L; Kürkçüoglu, CA; Metan, G; Yozgat, N | 1 |
| Chai, LYA; Chee, YL; Chng, WJ; Hsu, LY; Jin, J; Khoo, AL; Koh, LP; Lim, BP; Lim, SE; Poon, LM; Teng, M; Ying, D; Zhao, YJ | 1 |
| Gao, HH; Huang, S; Jing, Y; Li, Y; Liu, J; Yao, ZL | 1 |
| Cho, SY; Chung, DR; Kang, CI; Kim, SH; Ko, JH; Lee, NY; Peck, KR; Song, JH | 1 |
| Asch, J; Coombs, J; Ford, CD; Hoda, D; Lopansri, BK; Ostronoff, F; Stofer, MG; Webb, BJ | 1 |
| Bhagwati, G; Bhakuni, P; Chakrabarti, A; Chakrabarti, S; Jaiswal, SR; Joy, A | 1 |
| Asch, J; Bo Petersen, F; Burke, JP; Dascomb, KK; Ford, CD; Haydoura, S; Lopansri, BK; Snow, G | 1 |
| Hallböök, H; Lidström, AK; Pauksens, K | 1 |
| Torfoss, D | 1 |
| Ader, F; Alfandari, S; Berthon, C | 1 |
| Chai, LY; Chee, YL; Chng, WJ; Ding, Y; Hsu, LY; Jin, J; Lee, YM; Poon, LM; Tan, LK | 1 |
1 review(s) available for carbapenems and Febrile Neutropenia
| Article | Year |
|---|---|
Carbapenems versus alternative β-lactams monotherapy or in combination for febrile neutropenia: Systematic review and meta-analysis of randomized controlled trial.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Therapy, Combination; Febrile Neutropenia; Humans; Randomized Controlled Trials as Topic | 2020 |
1 trial(s) available for carbapenems and Febrile Neutropenia
| Article | Year |
|---|---|
Impact of Preemptive Granulocyte Infusions During Febrile Neutropenia in Patients Colonized with Carbapenem-Resistant Gram-Negative Bacteria Undergoing Haploidentical Transplantation.
Topics: Adolescent; Adult; Aged; Allografts; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Disease-Free Survival; Febrile Neutropenia; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Granulocytes; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Leukocyte Transfusion; Male; Middle Aged; Prospective Studies; Survival Rate; Time Factors | 2019 |
13 other study(ies) available for carbapenems and Febrile Neutropenia
| Article | Year |
|---|---|
Antimicrobial stewardship in high-risk febrile neutropenia patients.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Febrile Neutropenia; Humans; Middle Aged; Retrospective Studies | 2022 |
[Clinical Observation of Neutropenia Patients with Hematonosis Treated with Polymyxin B Sulfate].
Topics: Anti-Bacterial Agents; Carbapenems; Febrile Neutropenia; Humans; Polymyxin B; Tigecycline | 2022 |
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia.
Topics: Adult; Aged; Allografts; Anti-Bacterial Agents; Autografts; Azabicyclo Compounds; Bacteremia; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Febrile Neutropenia; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Retrospective Studies; Tazobactam; Treatment Outcome; Young Adult | 2021 |
A change for the antibacterial treatment policy to decrease carbapenem consumption at a haematopoietic stem cell transplantation centre.
Topics: Amikacin; Anti-Bacterial Agents; Carbapenems; Cross Infection; Febrile Neutropenia; Guidelines as Topic; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Penicillanic Acid; Piperacillin; Retrospective Studies; Tazobactam; Teicoplanin; Tertiary Care Centers; Treatment Outcome; Turkey; Vancomycin | 2017 |
Evaluation of a risk-guided strategy for empirical carbapenem use in febrile neutropenia.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Febrile Neutropenia; Humans; Invasive Pulmonary Aspergillosis; Piperacillin, Tazobactam Drug Combination; Prospective Studies | 2018 |
[Safety and Effectiveness of High Dose Tigecycline for Treating Patients with Acute Leukemia after Ineffctiveness of Carbapenems Chemotherapy Combinating with Febrile Neutropenia: Retrospective study].
Topics: Anti-Bacterial Agents; Carbapenems; Febrile Neutropenia; Humans; Minocycline; Retrospective Studies; Tigecycline | 2018 |
Evaluation of a Carbapenem-Saving Strategy Using Empirical Combination Regimen of Piperacillin-Tazobactam and Amikacin in Hemato-Oncology Patients.
Topics: Amikacin; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Febrile Neutropenia; Humans; Piperacillin, Tazobactam Drug Combination | 2019 |
Decrease in vancomycin-resistant Enterococcus colonization associated with a reduction in carbapenem use as empiric therapy for febrile neutropenia in patients with acute leukemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Febrile Neutropenia; Feces; Female; Gram-Positive Bacterial Infections; Humans; Leukemia; Male; Middle Aged; Multilocus Sequence Typing; Regression Analysis; Retrospective Studies; Vancomycin-Resistant Enterococci; Young Adult | 2019 |
Frequency, risk factors, and outcomes of vancomycin-resistant Enterococcus colonization and infection in patients with newly diagnosed acute leukemia: different patterns in patients with acute myelogenous and acute lymphoblastic leukemia.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Bacteremia; Carbapenems; Carrier State; Diarrhea; Febrile Neutropenia; Female; Gram-Positive Bacterial Infections; Humans; Length of Stay; Leukemia, Myeloid, Acute; Male; Middle Aged; Molecular Typing; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Risk Factors; Vancomycin-Resistant Enterococci; Young Adult | 2015 |
Ciprofloxacin prophylaxis delays initiation of broad-spectrum antibiotic therapy and reduces the overall use of antimicrobial agents during induction therapy for acute leukaemia: A single-centre study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Carbapenems; Ciprofloxacin; Cohort Studies; Febrile Neutropenia; Female; Humans; Leukemia; Male; Middle Aged; Mycoses | 2016 |
Carbapenems and febrile neutropenia - author's reply.
Topics: Carbapenems; Febrile Neutropenia; Humans; Norway; Time Factors; Treatment Outcome | 2017 |
Carbapenems and febrile neutropenia.
Topics: Carbapenems; Febrile Neutropenia; Humans; Norway; Time Factors; Treatment Outcome | 2017 |
Risk factors for adverse outcomes and multidrug-resistant Gram-negative bacteraemia in haematology patients with febrile neutropenia in a Singaporean university hospital.
Topics: Academic Medical Centers; Adult; Bacteremia; Carbapenems; Ceftazidime; Drug Resistance, Multiple; Febrile Neutropenia; Female; Gram-Negative Bacteria; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Prevalence; Prospective Studies; Risk Factors; Sepsis; Singapore; Tazobactam; Treatment Outcome; Universities | 2012 |